BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation

Fiona L. Dignan*, Robert F. Wynn, Nedim Hadzic, John Karani, Alberto Quaglia, Tony Pagliuca, Paul Veys, Michael N. Potter, Haemato-oncology Task Force, British Soc Blood Marrow

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    245 Citations (Scopus)

    Abstract

    A joint working group established by the Haemato-oncology subgroup of the British Committee for Standards in Haematology (BCSH) and the British Society for Blood and Marrow Transplantation (BSBMT) has reviewed the available literature and made recommendations for the diagnosis and management of veno-occlusive disease of the liver following haematopoietic stem cell transplantation (HSCT). This guideline includes recommendations for both prophylaxis and treatment of the condition and includes recommendations for children and adults undergoing HSCT.

    Original languageEnglish
    Pages (from-to)444-457
    Number of pages14
    JournalBritish Journal of Haematology
    Volume163
    Issue number4
    DOIs
    Publication statusPublished - Nov 2013

    Keywords

    • veno-occlusive disease
    • prophylaxis
    • transplant
    • defibrotide
    • sinusoidal obstruction syndrome
    • BONE-MARROW-TRANSPLANTATION
    • TISSUE-PLASMINOGEN ACTIVATOR
    • MOLECULAR-WEIGHT HEPARIN
    • GEMTUZUMAB OZOGAMICIN EXPOSURE
    • RANDOMIZED CONTROLLED-TRIAL
    • REGIMEN-RELATED TOXICITIES
    • PORTOSYSTEMIC SHUNT TIPS
    • HIGH-RISK POPULATION
    • MR-IMAGING FINDINGS
    • LOW-DOSE HEPARIN

    Fingerprint

    Dive into the research topics of 'BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation'. Together they form a unique fingerprint.

    Cite this